Rodriguez-Novoa S - Search Results

1

Pharmacogenetics of tenofovir treatment.

Rodriguez-Novoa S, Labarga P, Soriano V. Rodriguez-Novoa S, et al. Pharmacogenomics. 2009 Oct;10(10):1675-85. doi: 10.2217/pgs.09.115. Pharmacogenomics. 2009. PMID: 19842939 Review.

2

Combinations of nucleoside/nucleotide analogues for HIV therapy.

Barreiro P, García-Benayas T, Rendón A, Rodríguez-Novoa S, Soriano V. Barreiro P, et al. AIDS Rev. 2004 Oct-Dec;6(4):234-43. AIDS Rev. 2004. PMID: 15700622 Review.

3

Atazanavir: the advent of a new generation of more convenient protease inhibitors.

Barreiro P, Rendón A, Rodríguez-Nóvoa S, Soriano V. Barreiro P, et al. HIV Clin Trials. 2005 Jan-Feb;6(1):50-61. doi: 10.1310/NBL2-R2G6-6V09-LL4C. HIV Clin Trials. 2005. PMID: 15765311 Review.

4

Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.

Rodriguez-Novoa S, Barreiro P, Rendón A, Jiménez-Nacher I, González-Lahoz J, Soriano V. Rodriguez-Novoa S, et al. Clin Infect Dis. 2005 May 1;40(9):1358-61. doi: 10.1086/429327. Epub 2005 Mar 31. Clin Infect Dis. 2005. PMID: 15825040

5

Pharmacogenetics in HIV therapy.

Rodríguez-Nóvoa S, Barreiro P, Jiménez-Nacher I, Rendón A, Soriano V. Rodríguez-Nóvoa S, et al. AIDS Rev. 2005 Apr-Jun;7(2):103-12. AIDS Rev. 2005. PMID: 16092504 Review.

6

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.

Rodríguez Nóvoa S, Barreiro P, Rendón A, Barrios A, Corral A, Jiménez-Nacher I, González-Lahoz J, Soriano V. Rodríguez Nóvoa S, et al. Clin Infect Dis. 2006 Jan 15;42(2):291-5. doi: 10.1086/499056. Epub 2005 Dec 8. Clin Infect Dis. 2006. PMID: 16355344

7

Overview of the pharmacogenetics of HIV therapy.

Rodríguez-Nóvoa S, Barreiro P, Jiménez-Nácher I, Soriano V. Rodríguez-Nóvoa S, et al. Pharmacogenomics J. 2006 Jul-Aug;6(4):234-45. doi: 10.1038/sj.tpj.6500374. Epub 2006 Feb 7. Pharmacogenomics J. 2006. PMID: 16462814 Review.

8

Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.

García-Benayas T, Rendón AL, Rodríguez-Novóa S, Barrios A, Maida I, Blanco F, Barreiro P, Rivas P, González-Lahoz J, Soriano V. García-Benayas T, et al. AIDS Res Hum Retroviruses. 2006 Apr;22(4):333-7. doi: 10.1089/aid.2006.22.333. AIDS Res Hum Retroviruses. 2006. PMID: 16623636

9

Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia.

Rodríguez-Nóvoa S, Martín-Carbonero L, Barreiro P, González-Pardo G, Jiménez-Nácher I, González-Lahoz J, Soriano V. Rodríguez-Nóvoa S, et al. AIDS. 2007 Jan 2;21(1):41-6. doi: 10.1097/QAD.0b013e328011d7c1. AIDS. 2007. PMID: 17148966

10

Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy.

de Mendoza C, Martin-Carbonero L, Barreiro P, de Baar M, Zahonero N, Rodriguez-Novoa S, Benito JM, González-Lahoz J, Soriano V. de Mendoza C, et al. AIDS. 2007 Mar 12;21(5):583-8. doi: 10.1097/QAD.0b013e32805e8742. AIDS. 2007. PMID: 17314520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters